These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34746740)

  • 1. Metabolic Acidosis and Cardiovascular Disease in CKD.
    Collister D; Ferguson TW; Funk SE; Reaven NL; Mathur V; Tangri N
    Kidney Med; 2021; 3(5):753-761.e1. PubMed ID: 34746740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study.
    Reaven NL; Funk SE; Mathur V; Tangri N
    Kidney Med; 2023 May; 5(5):100622. PubMed ID: 37139081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.
    Djamali A; Singh T; Melamed ML; Stein JH; Aziz F; Parajuli S; Mohamed M; Garg N; Mandelbrot D; Wesson DE; Astor BC
    Am J Kidney Dis; 2019 Apr; 73(4):476-485. PubMed ID: 30704880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over Time.
    Mathur V; Reaven NL; Funk SE; Tangri N
    Kidney Med; 2023 Jan; 5(1):100573. PubMed ID: 36683962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing Serum Bicarbonate is Associated With Reduced Risk of Adverse Kidney Outcomes in Patients with CKD and Metabolic Acidosis.
    Tangri N; Ferguson TW; Reaven NL; Lai J; Funk SE; Mathur V
    Kidney Int Rep; 2023 Apr; 8(4):796-804. PubMed ID: 37069991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease.
    Cheng YL; Huang SC; Ho MY; Li YR; Yen CL; Chen KH; Sun WC; Fan PY; Chen JS; Lin C; Hsiao CC
    Front Pharmacol; 2023; 14():1146668. PubMed ID: 37251318
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
    Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study.
    Tangri N; Mathur V; Reaven NL; Funk SE; Whitlock RH; Wesson DE; Bushinsky DA
    Clin Kidney J; 2023 Jul; 16(7):1113-1121. PubMed ID: 37398692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.
    Tantisattamo E; Murray V; Obi Y; Park C; Catabay CJ; Lee Y; Wenziger C; Hsiung JT; Soohoo M; Kleine CE; Rhee CM; Kraut J; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2021; 52(4):304-317. PubMed ID: 33895727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results.
    Kim HJ; Ryu H; Kang E; Kang M; Han M; Song SH; Lee J; Jung JY; Lee KB; Sung S; Seong EY; Ahn C; Oh KH
    Front Med (Lausanne); 2021; 8():707588. PubMed ID: 34395482
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
    Tangri N; Mathur V; Reaven N; Funk SE; Wesson DE
    Am J Nephrol; 2022; 53(8-9):603-613. PubMed ID: 36349769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bicarbonate and long-term outcomes in CKD.
    Menon V; Tighiouart H; Vaughn NS; Beck GJ; Kusek JW; Collins AJ; Greene T; Sarnak MJ
    Am J Kidney Dis; 2010 Nov; 56(5):907-14. PubMed ID: 20605301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.